(1) A drug or device shall be deemed to be adulterated:
If it consists in whole or in part of any filthy, putrid, or decomposed substance;
If it has been produced, prepared, packed, or held under unsanitary conditions underwhich it may have been contaminated with filth or rendered injurious to health;
If it is a drug and the methods used in, or the facilities or controls used for, itsmanufacture, processing, packing, or holding do not conform to or are not operated or administered in conformity with current good manufacturing practice to assure that such drug meets the requirements of this part 4 as to safety and that such drug has the identity and strength and meets the quality and purity characteristics which it purports or is represented to possess;
If it is a drug and its container is composed, in whole or in part, of any poisonous ordeleterious substance which may render the contents injurious to health;
If it is a drug and it bears or contains, for purposes of coloring only, a color additivewhich is unsafe within the meaning of the federal act or section 25-5-413 (1);
If it is a color additive, the intended use of which in or on drugs is for purposes ofcoloring only, and is unsafe within the meaning of the federal act or section 25-5-413 (1);
If it purports to be or is represented as a drug, the name of which is recognized in anofficial compendium, and its strength differs from, or its quality or purity falls below, the standard set forth in such compendium. Such determination as to strength, quality, or purity shall be made in accordance with the tests or methods of assay set forth in such compendium or, in case of the absence or inadequacy of such tests or methods of assay, those prescribed under authority of the federal act. No drug defined in an official compendium shall be deemed to be adulterated under this paragraph (g) because it differs from the standard of strength, quality, or purity therefor set forth in such compendium if its difference in strength, quality, or purity from such standard is plainly stated on its label. Whenever a drug is recognized in both the United States pharmacopoeia and the homeopathic pharmacopoeia of the United States, it shall be subject to the requirements of the United States pharmacopoeia unless it is labeled and offered for sale as a homeopathic drug, in which case it shall be subject to the provisions of the homeopathic pharmacopoeia of the United States and not to those of the United States pharmacopoeia.
If it is not subject to the provisions of paragraph (g) of this subsection (1) and itsstrength differs from, or its purity or quality falls below, that which it purports or is represented to possess;
If it is a drug and any substance has been mixed or packed therewith so as to reduceits quality or strength or substituted wholly or in part therefor.
Source: L. 57: p. 434, § 14. CRS 53: § 66-22-14. C.R.S. 1963: § 66-20-14. L. 70: p. 204, § 8.